Business Relations Table

Beispiel: brt.php?search=wide&s=wide&p=adjective&o=wideness

BR-Relations: 22

From Domain	Role	To Domain	Path
litldog.com	>>isreferencefrom.png CID: 0	byomasstx.com	/byomass-announces-appointment-of-drs-declan-doogan-and-stephen-hoffman-to-board-of-directors/
litldog.com	>>isreferencefrom.png CID: 0	fortistx.com	/fortis-therapeutics-closes-40-million-series-a-financing-to-advance-novel-anti-cd46-therapeutic-to-treat-late-stage-prostate-cancer-and-multiple-myeloma/
litldog.com	>>isreferencefrom.png CID: 0	catalyspacific.com	/perspective/arialys-therapeutics-announces-first-anre-patient-treated-with-art5803-in-open-label-phase-2-study-and-fda-clearance-of-ind-for-randomized-phase-2-study
litldog.com	>>isreferencefrom.png CID: 0	chiesiventures.com	/glycomine-completes-enrollment-in-global-phase-2b-polar-study-of-glm101-for-the-treatment-of-pmm2-cdg/
litldog.com	>>isreferencefrom.png CID: 0	aerorxtx.com	/press-release/aerorx_therapeutics_announces_21_million_series_a_financing_to_advance_inhaled_aero-007_the_first_nebulized_laba_lama_for_copd_into_late-stage_clinical_development/
litldog.com	>>isreferencefrom.png CID: 0	arialysrx.com	/news/arialys-therapeutics-receives-fda-rare-pediatric-disease-designation-for-art5803-to-treat-anti-nmda-receptor-encephalitis
litldog.com	>>isreferencefrom.png CID: 0	trex.bio	/trexbio-to-participate-in-upcoming-investor-conferences-in-september/
litldog.com	>>isreferencefrom.png CID: 0	agentcapital.com	/2024/11/trexbio-announces-84-million-series-b-financing-to-advance-pipeline-of-first-in-class-immunology-programs-into-clinical-development/
litldog.com	>>isreferencefrom.png CID: 0	onchillespharma.com	/post/onchilles-pharma-announces-ind-clearance-for-n17350
litldog.com	>>isreferencefrom.png CID: 0	adventls.com	/category/private-companies/
litldog.com	>>isreferencefrom.png CID: 0	pheast.com	/news/pheast-therapeutics-announces-first-patient-treated-in-phase-1-clinical-trial-of-phst001-for-patients-with-advanced-solid-tumors
litldog.com	>>isreferencefrom.png CID: 0	big4bio.com	/regions/san-diego
litldog.com	>>isreferencefrom.png CID: 0	alltrna.com	/press/alltrna-featured-on-fast-companys-2024-world-changing-ideas-list-for-advancing-a-universal-trna-medicine-for-stop-codon-disease
litldog.com	>>isreferencefrom.png CID: 0	glycomine.com	/glycomine-announces-115-million-series-c-financing-to-advance-lead-drug-candidate-glm101-into-a-phase-2b-clinical-trial-for-pmm2-cdg/
litldog.com	>>isreferencefrom.png CID: 0	enlazatx.com	/press_release/enlaza-therapeutics-announces-strategic-collaboration-with-vertex-pharmaceuticals-to-develop-war-lock-drug-conjugates-and-t-cell-engagers-for-improved-conditioning-and-certain-autoimmune-diseases/
litldog.com	>>isreferencefrom.png CID: 0	nrgene.com	/press-release/nrgene-advanced-technology-partner-aws/
litldog.com	>>isreferencefrom.png CID: 0	genedit.com	/category/news/
litldog.com	>>isreferencefrom.png CID: 0	valoratherapeutics.com	/news-1/press-release
litldog.com	>>isreferencefrom.png CID: 0	pharmasalmanac.com	/articles/orum-therapeutics-announces-30-million-series-b-financing-to-advance-cell-penetrating-cell-specific-antibody-technology-for-novel-therapeutics
litldog.com	>>isreferencefrom.png CID: 0	thedigitalelevator.com	/blog/best-life-science-biotech-pr-agencies/

1 2 Nächste

Business Relations Table - o4.fyi ()

BR-Editor

Domain-Statistiken für "litldog.com"

BR-Relations: 22